AstraZeneca Pharma India Ltd. — Board/Management Information 2025

Feb 11, 2025

==> picture [478 x 66] intentionally omitted <==

February 11, 2025

The Manager- Listing

BSE Limited

Corporate Relationship Dept., 5[th] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort Mumbai – 400 001

The Manager- Listing

National Stock Exchange of India Limited

Exchange Plaza, 5[th] Floor, Plot No. C/1, G - Block Bandra –Kurla Complex, Bandra (E) Mumbai – 400 051

Dear Sir(s),

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) – Regulations, 2015 Appointment of Senior Management Personnel

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company have approved the appointment of Dr. Sandeep Arora as Director – Medical Affairs with effect from March 3, 2025.

In this regard, please find the details as required under the SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, attached herewith as Annexure – A .

Kindly take the above information on record.

For AstraZeneca Pharma India Limited

MANASA Digitally signed by MANASA RAMA RAMA Date: 2025.02.11 17:32:51 +05'30' Manasa. R Company Secretary

==> picture [452 x 59] intentionally omitted <==

==> picture [478 x 66] intentionally omitted <==

Annexure - A

==> picture [476 x 566] intentionally omitted <==

----- Start of picture text ----- Sl. Particulars DetailsNo1 Reason for change viz. Dr. Sandeep Arora appointed as Director – Medical Affairsappointment, resignation,removal, death or otherwise;2 Date of appointment/ cessation Effective March 3, 2025(as applicable) and term ofappointment Term of appointment – Full – time employement3 Brief Profile Dr. Sandeep Arora, a healthcare professional with over 20 yearsof experience in Pharmaceuticals, Vaccines, Medical Devices,and the broader Healthcare Industry.He currently serves as the Head of Medical Affairs and PatientServices at Takeda India, where he has been leading medicalstrategies and patient-centric initiatives since 2019. Prior to this,he was the Regional Medical Director for Terumo InterventionSystems, Asia Pacific, and served as the Director of Medical andClinical Affairs at Terumo India, managing medical functionsacross diverse markets.With a strong background in Medical Affairs, he has manageddiverse therapy portfolios, including Oncology, Hematology,Gastrointestinal and Inflammatory Disorders, Rare Diseases,Interventional Medicine, Vaccines, Cardiovascular, Metabolic,and Respiratory therapies. His expertise extends to leadingteams in Medical Affairs and Clinical Trials, designing, andimplementing disease-concept strategies, addressing care gaps,and generating evidence through disease insights and clinicaldevelopment.A trained medical doctor and pharmaceutical physician, heearned his medical degree from Maulana Azad Medical College,University of Delhi, and completed an Executive Managementprogram at the Indian Institute of Management, Bangalore. Heis a Board-Certified Medical Affairs Specialist (US) and holdsECFMG certification in Medical Science and Clinical Skills(US).4 Disclosure of relationships Not Applicablebetween directors----- End of picture text -----

==> picture [452 x 59] intentionally omitted <==